Factors associated with treatment persistence among people with Type 2 Diabetes Mellitus (T2DM) initiating basal insulin – real-world data from Germany
E Moennig, I Hadjiyianni, T Otto, D Cao, M De Koven, SU Karkare, P Saade, M Ketz, T Baumann, M Perez-Nieves · Diabetologie und Stoffwechsel · 2016 · Heft 04
Bibliografische Angaben
Zusammenfassung
Background: Little real-world data is available in Europe on treatment persistence in T2DM patients after basal insulin initiation. This study used German sick-fund data (2009 – 2012) to evaluate persistence patterns and factors associated with persistence during the first year of basal insulin treatment. Methods: Prescriptions for basal insulin during the first treatment year were evaluated for 2,069 T2DM adults (mean age 63yrs, 61.5% male) with an initial prescription of basal insulin (glargine 54.8%, detemir 11.1%, NPH 34.1%). Based on whether there were ≥90-day gaps in treatment, patients were classified as…
